-+ 0.00%
-+ 0.00%
-+ 0.00%

3 ASX Growth Companies With Insider Ownership And 53% Earnings Growth

Simply Wall St·09/14/2026 19:08:16
Listen to the news

As the Australian share market grapples with pressures from rising oil prices, climbing bond yields, and potential interest rate hikes, investors are keenly observing sectors that may offer resilience amid volatility. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong management confidence and alignment of interests with shareholders.

Top 10 Growth Companies With High Insider Ownership In Australia

Name Insider Ownership Earnings Growth
Wisr (ASX:WZR) 10.3% 94.2%
Starpharma Holdings (ASX:SPL) 19.3% 92%
SKS Technologies Group (ASX:SKS) 19.3% 27.7%
PDI Gold (ASX:PDI) 10.4% 63.6%
Forrestania Resources (ASX:FRS) 24.7% 126.7%
Emerald Resources (ASX:EMR) 18.3% 20.9%
DXN (ASX:DXN) 13.5% 129.3%
Austral Resources Australia (ASX:AR1) 23.5% 28.2%
Adveritas (ASX:AV1) 17.6% 99.9%
Advanced Engineered Materials (ASX:AEM) 35.1% 58.7%

Click here to see the full list of 111 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Cogstate (ASX:CGS)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Cogstate Limited is a neuroscience solutions company that focuses on the creation, validation, and commercialization of digital brain health assessments globally, with a market cap of A$511.46 million.

Operations: The company's revenue is primarily derived from its Clinical Trials segment, which includes precision recruitment tools and research, generating $58.37 million, while the Healthcare segment, including sports applications, contributes $2.50 million.

Insider Ownership: 26.8%

Earnings Growth Forecast: 20.9% p.a.

Cogstate demonstrates strong growth potential with earnings expected to grow significantly over the next three years, outpacing the Australian market. Despite trading at 42.2% below its estimated fair value, it boasts a high return on equity forecast of 27.1%. Recent announcements highlight record contracted revenue of US$118.5 million for FY27, enhancing earnings visibility and supporting future growth prospects amidst positive market conditions and strategic investments in technology-enabled scale.

ASX:CGS Earnings and Revenue Growth as at Sep 2026
ASX:CGS Earnings and Revenue Growth as at Sep 2026

Clarity Pharmaceuticals (ASX:CU6)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Clarity Pharmaceuticals Ltd (ASX:CU6) is a clinical stage radiopharmaceutical company focused on developing radiopharmaceutical products for oncology in Australia and the United States, with a market cap of A$798.39 million.

Operations: The company generates revenue of A$10.53 million from its radiopharmaceutical development segment.

Insider Ownership: 13%

Earnings Growth Forecast: 53.5% p.a.

Clarity Pharmaceuticals shows promising growth potential, with revenue forecasted to increase by 52.6% annually, surpassing the Australian market's average. Despite a significant net loss of A$107.24 million for FY26, insider ownership remains high and stable, indicating confidence in its long-term prospects. The SECuRE trial results highlight substantial efficacy in prostate cancer treatment, supporting future revenue growth as the company progresses toward profitability within three years amidst strategic leadership changes.

ASX:CU6 Ownership Breakdown as at Sep 2026
ASX:CU6 Ownership Breakdown as at Sep 2026

Energy One (ASX:EOL)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Energy One Limited provides software products, outsourced operations, and advisory services to wholesale energy, environmental, and carbon trading markets in Australasia and Europe, with a market cap of A$472.41 million.

Operations: The company generates revenue of A$69.56 million from its energy software industry segment, serving wholesale energy and carbon trading markets in Australasia and Europe.

Insider Ownership: 23.9%

Earnings Growth Forecast: 32.8% p.a.

Energy One Limited demonstrates strong growth potential with earnings forecasted to grow significantly at 32.8% annually, outpacing the Australian market average. Recent earnings results showed a 38% increase in net income to A$8.13 million for FY26, reflecting robust financial performance. The proposed acquisition by Volue AS for A$565 million underscores investor confidence despite insider ownership details being unavailable. The stock trades below its estimated fair value, offering potential upside if growth forecasts materialize as anticipated.

ASX:EOL Earnings and Revenue Growth as at Sep 2026
ASX:EOL Earnings and Revenue Growth as at Sep 2026

Summing It All Up

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.